[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"menstrual-health-intervention\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:menstrual-health-intervention":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100644466","phase-4-period-pills-for-menstrual-regulation-a-new-reproductive-health-option-100644466",false,"NCT07671989","Period Pills for Menstrual Regulation: A New Reproductive Health Option","Period Pills","Inclusion Criteria:\n\n* Be 18 years old or older\n* Read and speak English\n* Know the date of their last menstrual period within 2 days\n* Have a period that is late by up to 21 days\n* Must have had regular periods in the last 4 months\n* Does not want to be pregnant\n* Does not want to verify pregnancy status\n* Understand that if they are pregnant, the pills will end their pregnancy\n* Does not have contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)\n\nExclusion Criteria:\n\n* Under 18 years old\n* Does not read and speak English\n* Does not know the date of their last menstrual period within 2 days\n* Has not had regular periods in the last 4 months\n* Wants to be pregnant\n* Wants to verify pregnancy status\n* Does not display understanding that if they are pregnant, the pills will end their pregnancy\n* Has any contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone\u002Fmisoprostol\u002Fprostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)",true,"FEMALE","18 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.",[27,28],"Menstrual Regulation","Menstrual Health Intervention",[30,31,32],"late period","missed period","mestruation","RECRUITING","2026-06-22",{"date":36,"type":37},"2026-06-26","ACTUAL",{"date":34,"type":37},{"date":40,"type":21},"2027-05-31",{"name":42,"class":43},"University of California, San Francisco","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":58,"conditions":59,"keywords":71,"overallStatus":75,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":85},"100628155","effectiveness-of-an-mhealth-innovation-on-the-impact-of-menstrual-complaints-in-adolescents-100628155","NCT07457957","Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents","The Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents - A Randomised Controlled Trial","MGA","Inclusion Criteria:\n\n* Dutch, English, Turkish or Moroccan-Arabic speaking\n* Post menarche\n* Access to a smartphone or tablet with iOS or Android operating system\n\nExclusion Criteria:\n\n* Amenorrhea\n* Pregnancy\n* No menstrual bleeding or withdrawel bleeding in the 3 months prior to inclusion.\n* Previously or currently under treatment by a health care provider for menstrual complaints","12 Years","21 Years",{"count":55,"type":21},874,[57],"NA","The aim of this study is to improve menstrual health-related quality of life in adolescents by using a mobile menstrual health tracker. We will perform a randomized controlled trial to evaluate the (cost)-effectiveness of this mHealth intervention.",[60,61,62,63,64,65,66,67,68,69,28,70],"Dysmenorrhea","Heavy Menstrual Bleeding","Menstrual Cramps","Menstrual Bleeding, Heavy","Menstrual Discomfort","Menstrual Cycle Abnormal","Menstrual Disorder","Menstrual Health","Mobile Application","mHealth","Adolescent",[72,69,73,70,74],"randomized clinical trial","Menstrual health","Menstrual Tracker App","NOT_YET_RECRUITING","2026-03-04",{"date":78,"type":37},"2026-03-09",{"date":80,"type":21},"2026-02-16",{"date":82,"type":21},"2029-05-31",{"name":84,"class":43},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",1]